pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Study finds SNAP soda bans cut purchases by 12% among beneficiaries

Aug 24, 2026·read at STAT ↗RegulatoryPositive

A new study shows that purchases of soda fell by roughly 12% among people receiving Supplemental Nutrition Assistance Program benefits after the bans on soda and candy took effect in ten states. The reduction translates to about 34 fewer 12‑ounce cans per person each year.

The restrictions are part of the Make America Healthy Again initiative, which aims to limit the use of food assistance dollars for sugary drinks and sweets. Critics had warned that consumers might simply shift spending to other money sources to buy the same products.

Study authors say the decline is modest but meaningful, noting that any drop in sugary‑drink consumption could help address obesity and related health concerns. The research, released by the National Bureau of Economic Research, has not yet undergone peer review.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Americans bought 12% less soda under new SNAP restrictions, study says”

read at STAT ↗
967 words · retrieved 59m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
Obesity3Type 2 Diabetes2
topics
Type 2 Diabetes5Obesity4CardiologyGene Therapy (AAV)Oncology

related stories

  • Dec 22Fierce Biotech Fundraising Tracker '26: Abcuro secures $66M; InduPro assembles $77MFierce Biotech
  • Jul 20Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independenceBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 4Male puberty is understudied — but when it starts may predict long-term health risksSTAT
  • May 12Second Clinical Scenario - Progressive Disease Despite Hematocrit Controlonclive